NasdaqCM - Nasdaq Real Time Price USD
Jasper Therapeutics, Inc. (JSPR)
4.7450
+0.1850
+(4.06%)
As of 1:28:27 PM EDT. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
79,899
94,892
48,361
93,654
Total Liabilities Net Minority Interest
18,225
16,452
12,372
24,136
Total Equity Gross Minority Interest
61,674
78,440
35,989
69,518
Total Capitalization
61,674
78,440
35,989
69,518
Common Stock Equity
61,674
78,440
35,989
69,518
Capital Lease Obligations
1,813
2,786
3,651
2,885
Net Tangible Assets
61,674
78,440
35,989
69,518
Working Capital
60,574
76,564
34,666
79,811
Invested Capital
61,674
78,440
35,989
69,518
Tangible Book Value
61,674
78,440
35,989
69,518
Total Debt
1,813
2,786
3,651
2,885
Share Issued
15,001.3530
11,163.8960
3,804.5670
3,785.5110
Ordinary Shares Number
15,001.3530
11,163.8960
3,804.5670
3,785.5110
12/31/2021 - 1/10/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TIL Instil Bio, Inc.
19.47
-5.12%
ADIL Adial Pharmaceuticals, Inc.
0.7010
-3.84%
LCTX Lineage Cell Therapeutics, Inc.
0.4752
+0.68%
BCYC Bicycle Therapeutics plc
8.28
-4.56%
PTGX Protagonist Therapeutics, Inc.
44.45
-3.72%
ACRV Acrivon Therapeutics, Inc.
1.9150
-4.25%
RLMD Relmada Therapeutics, Inc.
0.7033
+1.93%
NMRA Neumora Therapeutics, Inc.
0.7445
+4.72%
TARA Protara Therapeutics, Inc.
4.2000
0.00%
PYXS Pyxis Oncology, Inc.
1.0800
0.00%